To Evaluate The Effect Of SAR153191 (REGN88) Added To Other RA Drugs In Patients With RA Who Are Not Responding To Or Intolerant Of Anti-TNF Therapy (SARIL-RA-TARGET)
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Sanofi
Related studies linked through entity extraction aliases.
Study of Alirocumab (REGN727/SAR236553) in Patients With Primary Hypercholesterolemia and Moderate, High, or Very High Cardiovascular (CV) Risk, Who Are Intolerant to Statins (ODYSSEY ALTERNATIVE)
- Status
- COMPLETED
- Phase
- PHASE3
Study of Alirocumab (REGN727/SAR236553) in Patients With heFH (Heterozygous Familial Hypercholesterolemia) Who Are Not Adequately Controlled With Their LMT (Lipid-Modifying Therapy)
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of the Fixed Dose Combination of Glimepiride+Metformin in Type 2 Diabetic Patients Inadequately Controlled
- Status
- COMPLETED
- Phase
- PHASE3
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor
- Status
- COMPLETED
- Phase
- PHASE2
Study of Cabazitaxel in Patients With Metastatic Breast Cancer Previously Treated With Taxanes
- Status
- COMPLETED
- Phase
- PHASE2
Timing of Meal Insulin Boluses for Optimal Postprandial Glycemic Control in Type 1 Diabetes
- Status
- COMPLETED
- Phase
- NA
Interaction Study to Assess the Pharmacokinetic Interaction of Oral Administration of Rifapentine on ATRIPLA™ in HIV Patients
- Status
- COMPLETED
- Phase
- PHASE1
Imaging for Response Assessment of Neoadjuvant Chemotherapy in Primary Breast Cancer (GALADON)
- Status
- TERMINATED
- Phase
- PHASE2
Comparison of a New Formulation of Insulin Glargine With Lantus® Both in Combination With Oral Antihyperglycemic Drug(s) in Japanese Patients With Type 2 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- PHASE3
Comparison of a New Formulation of Insulin Glargine With Lantus® in Japanese Patients With Type 1 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- PHASE3
Nesvacumab (REGN910/ SAR307746) and Aflibercept ("Ziv-aflibercept" in the U.S.) in Patients With Advanced Solid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- PHASE3
Repeated Dose Study With a New Insulin Glargine Formulation and Lantus® on 24-hour Glucose Profile in Japanese Patients With Type 1 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- PHASE1
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy
- Status
- COMPLETED
- Phase
- PHASE3
A Phase I/Ib Trial for the Evaluation of SAR260301 in Monotherapy or in Combination With Vemurafenib in Patients With Various Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Pharmacokinetic and Tolerability of Alirocumab SAR236553 (REGN727) in Patients With Hepatic Impairment and in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Colorectal Cancer Metastatic
- Status
- COMPLETED
- Phase
- PHASE3
Adjuvant Aflibercept for Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Treatment of Locally Advanced or Metastatic Transitional Cell Carcinoma With Cabazitaxel
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3